| Product Name | Sitravatinib - API |
| Product Code | DA-S203-a |
| Chemical name | Sitravatinib |
| Synonyms | N'1-(3-fluoro-4-{[2-(5-{[(2-methoxyethyl)amino]methyl}pyridin-2-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; |
| Impurity | NA |
| CAS Number | 1123837-84-2 |
| Alternate CAS # | NA |
| Molecular form | C33H29F2N5O4S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 629.68 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | Sitravatinib is under investigation in clinical trial NCT03680521 (Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma). |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
